Sirolimus versus mycophenolate mofetil for triple immunosuppression in thyroid eye disease patients with recent‐onset intractable diplopia: A prospective comparative case series
Kenneth Ka Hei Lai, Yue Wang, Chi Pui Pang, Kelvin Kam Lung Chong
Abstract
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. FIGURE S1. Coronal plane of orbital MRI (STIR sequence) of patient No. 9 showed significant improvement of size of affected extraocular muscles (A = Baseline, B = 12 months after triple-immunosuppressant with sirolimus). FIGURE S2. Coronal plane of orbital MRI (STIR sequence) of patient No. 10 showed significant improvement of size of affected affected extraocular muscles (A = Baseline, B = 12 months after triple-immunosuppressant with sirolimus). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.